Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
No clinical trials in humans have established short or long-term safety
Comprehensive evaluation helps identify contributing factors requiring direct treatment
In: Peptides, 7(6), pp
Safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a dual GLP-1/GIP receptor agonist (HRS9531) in T2DM patients: a randomized, double-blind, placebo- and open-label positive-controlled phase 1b trial
I slept through until 5:30 AM without my usual middle-of-the-night wake-up
US$ 27.62
US$ 28.56
US$ 22.84
US$ 20.21
US$ 24.47
US$ 28.28
US$ 25.19
